| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/04/2006 | US20060094726 Quinoline derivatives as nk-2 and nk-3 receptor antagonists |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094719 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | US20060094716 1-Pyridin-4-yl-urea derivatives |
| 05/04/2006 | US20060094710 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 05/04/2006 | US20060094702 5-HT4 receptor antagonists |
| 05/04/2006 | DE19515251B4 Faserreaktive Disazofarbstoffe Fiber-reactive disazo dyes |
| 05/04/2006 | CA2585638A1 Aminopyridine derivatives having aurora a selective inhibitory action |
| 05/04/2006 | CA2585177A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 05/04/2006 | CA2585174A1 Substituted pyridoxines as anti-platelet agents |
| 05/04/2006 | CA2585030A1 New indole or benzimidazole derivatives |
| 05/04/2006 | CA2584752A1 Triazoles useful as inhibitors of protein kinases |
| 05/04/2006 | CA2584409A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2584318A1 Quinoline derivatives |
| 05/04/2006 | CA2584241A1 Cgrp receptor antagonists |
| 05/04/2006 | CA2580119A1 Amorphous object of cinnamide compound |
| 05/03/2006 | EP1652847A1 Quinoline and quinazoline derivatives for the treatment of tumors |
| 05/03/2006 | EP1652841A1 Novel phenantridine analogues and their use as inhibitors of hyperproliferation of T cells and/or keratinocytes |
| 05/03/2006 | EP1652524A1 Dry syrup containing loratadine |
| 05/03/2006 | EP1651647A1 Nicotinamide derivatives useful as pdea4 inhibitors |
| 05/03/2006 | EP1651643A2 Bicyclic compounds and compositions as pdf inhibitors |
| 05/03/2006 | EP1651636A1 Substituted heterocyclic diarylamine analogues |
| 05/03/2006 | EP1651635A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651634A1 Imidazol derivatives of piperidine as histamine antagonists |
| 05/03/2006 | EP1651633A1 Substituted lactams and their use as anti-cancer agents |
| 05/03/2006 | EP1651632A1 Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonists |
| 05/03/2006 | EP1651631A1 Bicyclic imidazol derivatives against flaviviridae |
| 05/03/2006 | EP1651630A1 An improved process for the preparation of moxifloxacin hydrochloride |
| 05/03/2006 | EP1651623A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/03/2006 | EP1651622A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 05/03/2006 | EP1651621A1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 05/03/2006 | EP1651619A1 Substituted pyrimidin-4-ylamin analogues as vanilloid receptor ligands |
| 05/03/2006 | EP1651613A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 05/03/2006 | EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/03/2006 | EP1651609A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651608A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651600A2 Novel n -substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof |
| 05/03/2006 | EP1651599A1 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | EP1651220A1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 05/03/2006 | EP1651209A2 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1546128B1 Pyrimidine derivatives as selective cox-2 inhibitors |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1499606B1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists |
| 05/03/2006 | EP1444224B1 3-substituted oxindole beta-3 agonists |
| 05/03/2006 | EP1444200B1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 05/03/2006 | EP1390351B1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 05/03/2006 | EP1351954B1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 05/03/2006 | EP1248771B1 Method for preparing hydroxypicolinic acid derivatives |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 05/03/2006 | EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands |
| 05/03/2006 | EP1133489B9 Isonipecotamides for the treatment of integrin-mediated disorders |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | EP1074542B1 Sulfonamide-containing indole compounds |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | EP0672042B1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 05/03/2006 | CN1768055A 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1768053A Pyrazole compounds. |
| 05/03/2006 | CN1768052A Substituted pyrazole compounds |
| 05/03/2006 | CN1768051A Substituted pyrazoles |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 05/03/2006 | CN1768041A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 05/03/2006 | CN1768037A Chemical compounds. |
| 05/03/2006 | CN1765895A Nolatrexed hydrochloride synthesis process |
| 05/03/2006 | CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 05/03/2006 | CN1254473C Process for crystallization of(R)-or(S)-lansoprazole |
| 05/02/2006 | US7038057 Alkylation, acylation |
| 05/02/2006 | US7038052 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7038049 Anticancer agents; antitumor agents; apoptosis of breast tumor cells; drug resistance leukemia |
| 05/02/2006 | US7037935 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 05/02/2006 | US7037931 CCK-1 receptor modulators |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037924 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037917 Nitrogen compounds such as 4-((4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2 -pyrimidinyl)amino)benzonitrile, used as protease inhibitors for prophylaxis of viral diseases |
| 05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
| 05/02/2006 | US7037913 Piperazinyl derivatives of naphthalenes, (iso)quinolines and naphthyridines; used particularly the treatment of HIV and AIDS. |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037908 HIV integrase inhibitors |
| 05/02/2006 | US7037880 Ethylene derivatives and pesticides containing said derivatives |
| 05/02/2006 | CA2358394C Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 05/02/2006 | CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 05/02/2006 | CA2149147C Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 04/27/2006 | WO2006044955A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044602A2 Diphenyl substituted alkanes as flap inhiibitors |
| 04/27/2006 | WO2006044527A1 Imidazole derivatives as vanilloid receptor ligands |
| 04/27/2006 | WO2006044454A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | WO2006044362A2 N-sulfonylpiperidine cannabinoid receptor 1 antagonists |
| 04/27/2006 | WO2006044355A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 04/27/2006 | WO2006044000A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006043595A1 Process for producing 2-cyano-4-fluoropyrrolidine derivative |